Author:
SHIGA Tsuyoshi,HASHIGUCHI Masayuki,TANAKA Takanori,MOROZUMI Naomi,IRIE Shin,MOCHIZUKI Mayumi,HAGIWARA Nobuhisa,KASANUKI Hiroshi
Publisher
Japanese Society of Clinical Pharmacology and Therapeutics
Subject
Pharmacology (medical),Pharmacology
Reference26 articles.
1. Hattori Y, Hidaka T, Aisaka K, Satoh F, Ishihara T. Effect of SUN 1165, a new potent antiarrhythmic agent, on the kinetics of rate-dependent block of Na channels and ventricular conduction of extrasystoles. J Cardiovasc Pharmacol.1988; 11(4): 407-12.
2. Aisaka K, Hidaka T, Inomata N, Hamasaki S, Ishihara T, Morita M. N-(2,6-Dimethylphenyl) -8-pyrrolizidine acetamide hydrochloride hemihydrate (SUN 1165): a new potent and long-acting antiarrhythmic agent. Arzneimittelforschung.1985; 35 (8): 1239-45.
3. Atarashi H, Inoue H, Hiejima K, Hayakawa H, for the PSTAF Investigators. Conversion of recent-onset atrial fibrillation by a single oral dose of pilsicainide (Pilsicainide Suppression Trial on Atrial Fibrillation). Am J Cardiol.1996; 78(6): 694-7.
4. Okishige K, Nishizaki M, Azegami K, Igawa M, Yamawaki N, Aonuma K. Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: a placebo-controlled, multicenter study. Am Heart J.2000; 140(3): e13.
5. Komatsu T, Sato Y, Tachibana H, Nakamura M, Horiuchi D, Okumura K. Randomized crossover study of the long-term effects of pilsicainide and cibenzoline in preventing recurrence of symptomatic paroxysmal atrial fibrillation: influence of the duration of arrhythmia before therapy. Circ J. 2006; 70(6): 667- 72.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献